甲状腺激素对脓毒症脏器功能维护作用的研究进展

摘要/Abstract

中图分类号:

R593.2

周易, 陈影, 陈尔真. 甲状腺激素对脓毒症脏器功能维护作用的研究进展[J]. 内科理论与实践, 2022, 17(05): 408-412.

ZHOU Yi, CHEN Ying, CHEN Erzhen. Research progress of thyroid hormone on organ function maintenance in sepsis[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 408-412.

参考文献39

[1]	Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. doi:10.1001/jama.2016.0287pmid:26903338
[2]	Burmann B, Mchowat J, Hiller S, et al. Mutual modulation of MIF and bacterial endotoxin may play an important role in the pathogenesis of sepsis[J]. Shock, 2016, 451(6): 107-113.
[3]	Georgescu AM, Banescu C, Azamfirei R, et al. Evaluation of TNF-α genetic polymorphisms as predictors for sepsis susceptibility and progression[J]. BMC Infect Dis, 2020, 20(1): 221. doi:10.1186/s12879-020-4910-6pmid:32171247
[4]	Samuels JM, Moore HB, Moore EE. Coagulopathy in severe sepsis: interconnectivity of coagulation and the immune system[J]. Surg Infect (Larchmt), 2018, 19(2): 208-215. doi:10.1089/sur.2017.260 URL
[5]	Luo B, Yu Z, Li Y. Thyroid hormone disorders and sepsis[J]. Biomed Mater Eng, 2017, 28(s1): S237-S241.
[6]	Heming N, Sivanandamoorthy S, Meng P, et al. Immune effects of corticosteroids in sepsis[J]. Front Immunol, 2018, 9: 1736. doi:10.3389/fimmu.2018.01736pmid:30105022
[7]	Bloise FF, Santos AT, de Brito J, et al. Sepsis impairs thyroid hormone signaling and mitochondrial function in the mouse diaphragm[J]. Thyroid, 2020, 30(7): 1079-1090. doi:10.1089/thy.2019.0124pmid:32200709
[8]	Fliers E, Kalsbeek A, Boelen A. Beyond the fixed setpoint of the hypothalamus-pituitary-thyroid axis[J]. Eur J Endocrinol, 2014, 171(5): 197-208. doi:10.1530/EJE-14-0285pmid:25005935
[9]	de Luca R, Davis PJ, Lin HY, et al. Thyroid hormones interaction with immune response, inflammation and non-thyroidal illness syndrome[J]. Front Cell Dev Biol, 2021, 8: 614030. doi:10.3389/fcell.2020.614030 URL
[10]	Peeters RP, Wouters PJ, Kaptein E, et al. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients[J]. J Clin Endocrinol Metab, 2003, 88(7): 3202-3211. doi:10.1210/jc.2002-022013 URL
[11]	Ellender T, Benzoni N. Updates in sepsis resuscitation[J]. Emerg Med Clin North Am, 2020, 38(4): 807-818. doi:10.1016/j.emc.2020.06.006 URL
[12]	van den Berghe G. On the neuroendocrinopathy of critical illness[J]. Am J Respir Crit Care Med, 2016, 194(11): 1337-1348. doi:10.1164/rccm.201607-1516CI URL
[13]	Fliers E, Bianco AC, Langouche L, et al. Thyroid function in critically ill patients[J]. Lancet Diabetes Endocrinol, 2015, 3(10): 816-825. doi:10.1016/S2213-8587(15)00225-9 URL
[14]	Fliers E, Boelen A. An update on non-thyroidal illness syndrome[J]. J Endocrinol Invest, 2021, 44(8): 1597-1607. doi:10.1007/s40618-020-01482-4pmid:33320308
[15]	Angelousi AG, Karageorgopoulos DE, Kapaskelis AM, et al. Association between thyroid function tests at baseline and the outcome of patients with sepsis or septic shock[J]. Eur J Endocrinol, 2011, 164(2): 147-155. doi:10.1530/EJE-10-0695pmid:21078686
[16]	Lee S, Farwell AP. Euthyroid sick syndrome[J]. Compr Physiol, 2016, 6(2): 1071-1080. doi:10.1002/cphy.c150017pmid:27065175
[17]	Das N, Kumar TR. Molecular regulation of follicle-stimulating hormone synthesis, secretion and action[J]. J Mol Endocrinol, 2018, 60(3): R131-R155. doi:10.1530/JME-17-0308 URL
[18]	Ojamaa K. Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy[J]. Vascul Pharmacol, 2010, 52(4): 113-119. doi:10.1016/j.vph.2009.11.008 URL
[19]	Chattergoon NN. Thyroid hormone signaling and consequences for cardiac development[J]. J Endocrinol, 2019, 242(1): T145-T160. doi:10.1530/JOE-18-0704
[20]	Fattahi F, Ward PA. Complement and sepsis-induced heart dysfunction[J]. Mol Immunol, 2017, 84: 57-64. doi:S0161-5890(16)30245-0pmid:27931779
[21]	Stengl M, Bartak F, Sykora R, et al. Reduced L-type calcium current in ventricular myocytes from pigs with hyperdynamic septic shock[J]. Crit Care Med, 2010, 38(2): 579-587. doi:10.1097/CCM.0b013e3181cb0f61pmid:20029342
[22]	Ksenzenko SM, Davidson SB, Saba AA, et al. Effect of triiodothyronine augmentation on rat lung surfactant phospholipids during sepsis[J]. J Appl Physiol(1985), 1997, 82(6): 2020-2027.
[23]	Al-Saiedy M, Pratt R, Lai P, et al. Dysfunction of pulmonary surfactant mediated by phospholipid oxidation is cholesterol-dependent[J]. Biochim Biophys Acta Gen Subj, 2018, 1862(4): 1040-1049. doi:10.1016/j.bbagen.2018.01.008 URL
[24]	Sungurlu S, Kuppy J, Balk RA. Role of antithrombin Ⅲ and tissue factor pathway in the pathogenesis of sepsis[J]. Crit Care Clin, 2020, 36(2): 255-265. doi:S0749-0704(19)30097-1pmid:32172812
[25]	Ali S, Majid S, Niamat Ali M, et al. Evaluation of etiology and pregnancy outcome in recurrent miscarriage patients[J]. Saudi J Biol Sci, 2020, 27(10): 2809-2817. doi:10.1016/j.sjbs.2020.06.049pmid:32994741
[26]	Fernández V, Videla LA. On the mechanism of thyroid hormone-induced respiratory burst activity in rat polymorphonuclear leukocytes[J]. Free Radic Biol Med, 1995, 19(3): 359-363. doi:10.1016/0891-5849(95)00016-Q URL
[27]	Radman M, Portman MA. Thyroid hormone in the pediatric intensive care unit[J]. J Pediatr Intensive Care, 2016, 5(4): 154-161. doi:10.1055/s-0036-1583280pmid:31110900
[28]	Alamino VA, Montesinos MM, Rabinovich GA, et al. The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity[J]. Oncoimmunology, 2016, 5(1): e1064579. doi:10.1080/2162402X.2015.1064579 URL
[29]	Yildizdaş D, Onenli-Mungan N, Yapicioğlu H, et al. Thyroid hormone levels and their relationship to survival in children with bacterial sepsis and septic shock[J]. J Pediatr Endocrinol Metab, 2004, 17(10): 1435-1442. pmid:15526723
[30]	Lado-Abeal J. Non-thyroidal illness syndrome, the hidden player in the septic shock induced myocardial contractile depression[J]. Med Hypotheses, 2020, 142: 109775. doi:10.1016/j.mehy.2020.109775 URL
[31]	Kim JG, Shin H, Kim W, et al. The value of decreased thyroid hormone for predicting mortality in adult septic patients[J]. Sci Rep, 2018, 8(1): 14137. doi:10.1038/s41598-018-32543-7 URL
[32]	Liu YC, Jiang TY, Chen ZS, et al. Thyroid hormone disorders: a predictor of mortality in patients with septic shock defined by Sepsis-3?[J]. Intern Emerg Med, 2021, 16(4): 967-973. doi:10.1007/s11739-020-02546-2 URL
[33]	Foks M, Dudek A, Polok K, et al. Thyroid hormones as potential prognostic factors in sepsis[J]. Anaesthesiol Intensive The, 2019, 51(3): 205-209.
[34]	Kothiwale VA, Patil P, Gaur S. Correlation of thyroid hormone profile with the acute physiology and chronic health evaluation Ⅱ score as a prognostic marker in patients with sepsis in the intensive care unit[J]. J Assoc Physicians India, 2018, 66(7): 59-62. pmid:31325264
[35]	Li X, Zhu Z, Zhou T, et al. Predictive value of combined serum FGF21 and free T₃for survival in septic patients[J]. Clin Chim Acta, 2019, 494: 31-37. doi:10.1016/j.cca.2019.03.005 URL
[36]	Inan M, Koyuncu A, Aydin C, et al. Thyroid hormone supplementation in sepsis: an experimental study[J]. Surg Today, 2003, 33(1): 24-29. pmid:12560903
[37]	詹峰, 宋维, 陈文腾, 等. 小剂量左旋甲状腺素干预严重脓毒症合并正常甲状腺功能病态综合征患者疗效观察[J]. 中国急救医学, 2017, 37(2): 105-108.
[38]	Frau C, Godart M, Plateroti M. Thyroid hormone regulation of intestinal epithelial stem cell biology[J]. Mol Cell Endocrinol, 2017, 459: 90-97. doi:S0303-7207(17)30170-3pmid:28288904
[39]	Shirali AS, Wu JX, Zhu CY, et al. The role of serum procalcitonin in predicting bacterial sepsis in patients with hypothyroidism[J]. J Clin Endocrinol Metab, 2019, 104(12): 5915-5922. doi:10.1210/jc.2019-01082pmid:31361312

甲状腺激素对脓毒症脏器功能维护作用的研究进展

Research progress of thyroid hormone on organ function maintenance in sepsis

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献39

相关文章15

编辑推荐

Metrics

本文评价

[1]	尹彦江, 罗治文, 陈晓, 张业繁, 黄振, 赵宏, 赵建军, 李智宇, 周健国, 蔡建强, 毕新宇.肝内胆管癌病人肝脏手术切缘与预后的关系[J]. 外科理论与实践, 2022, 27(3): 221-228.
[2]	杨崔燕, 王豪雨, 陈小松, 沈坤炜.抑癌基因TP53突变状态与三阴性乳腺癌病人预后的研究[J]. 外科理论与实践, 2022, 27(05): 421-428.
[3]	周思锋, 徐海舒, 范欣生.基于不同生物样本代谢组学的OSAHS生物标志物研究进展[J]. 诊断学理论与实践, 2022, 21(04): 535-540.
[4]	郑毓真, 郑彦俊, 周易, 祁星, 陈薇薇, 史雯, 周伟君, 杨之涛, 陈影, 毛恩强, 陈尔真.综合性医院674例脓毒症住院患者的回顾性临床分析[J]. 内科理论与实践, 2022, 17(04): 278-282.
[5]	徐娜娜, 吴涛, 寇明坤, 白海.ASXL1基因突变在急性髓系白血病中的研究进展[J]. 内科理论与实践, 2022, 17(04): 353-355.
[6]	程威, 黄雨桦, 王剑, 李幼生.影响癌性肠梗阻病人预后的多因素分析[J]. 外科理论与实践, 2022, 27(04): 340-345.
[7]	陈敏, 车在前, 陈影, 马丽, 赵冰, 周伟君, 毛恩强, 陈尔真.白细胞血小板比值早期评估脓毒症预后的临床研究[J]. 内科理论与实践, 2022, 17(03): 208-213.
[8]	李蕾, 袁菲, 王朝夫, 许海敏, 王婷.101例壶腹部腺癌临床病理及预后因素分析[J]. 诊断学理论与实践, 2022, 21(03): 355-361.
[9]	潘琼, 李明巧, 谭雅, 余思睿, 柴进.胆酸转运蛋白调控胆汁酸代谢的分子机制[J]. 内科理论与实践, 2022, 17(01): 4-10.
[10]	李响, 王杨, 葛晓利, 潘曙明.中药虎杖治疗脓毒症的研究进展[J]. 内科理论与实践, 2022, 17(01): 92-96.
[11]	沐阳, 陈欣.血浆降钙素原和C反应蛋白对多发伤病人预后评估的价值[J]. 外科理论与实践, 2021, 26(6): 532-536.
[12]	符国新王舒舒何垚宋晓萌朱载瓯.腮腺手术中应用美容切口与 Blair 切口比较的系统评价及 Meta 分析[J]. 组织工程与重建外科杂志, 2021, 17(6): 532-.
[13]	孙烁烁, 韦晓, 陈国芳, 刘超.儿童亚临床甲状腺功能减退的诊治：困惑与共识[J]. 内科理论与实践, 2021, 16(06): 438-441.
[14]	曹维, 陈柔柔, 谢媛, 邹婧, 赫荣波, 钱莉, 刘煜.不同体质量指数多囊卵巢综合征患者内分泌代谢特征的临床研究[J]. 内科理论与实践, 2021, 16(06): 381-386.
[15]	赵晴晴, 周金鑫, 潘昱, 琚卉君, 朱丽颖, 刘瑒, 张一帆.高剂量糖皮质激素对大鼠糖代谢的影响[J]. 内科理论与实践, 2021, 16(06): 397-403.